Steve Ubl, CEO of PhRMA since 2015, announced plans to step down at the end of 2026 after over a decade in the role.1236
He will remain in position until a successor is found, ensuring a seamless transition.136
The announcement was made during a PhRMA board call on April 8, 2026.3
Ubl led PhRMA through challenges including the COVID-19 pandemic, drug pricing reforms under Democrats, and Trump administration deals and tariffs on drug imports.134
PhRMA board chair and Merck CEO Rob Davis praised Ubl's leadership.3
Ubl expressed pride in accomplishments and commitment to PhRMA's priorities during transition.36
Sources:
1. https://www.statnews.com/2026/04/08/phrma-ceo-steve-ubl-step-down/
2. https://www.fiercepharma.com/pharma/steven-ubl-set-depart-after-decade-plus-ceo-phrma
3. https://www.politico.com/news/2026/04/08/top-drug-lobbyist-to-depart-phrma-at-year-end-00863907
4. https://www.axios.com/2026/04/08/top-pharmaceutical-lobbyist-steps-down
6. https://www.phrma.org/resources/phrma-president-ceo-steve-ubl-announces-plans-for-leadership-transition